These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3459567)

  • 1. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia.
    Scallet AC; Olney JW
    Brain Res; 1986 May; 374(2):380-4. PubMed ID: 3459567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic neurotoxins alter the content of immunoreactive cholecystokinin in pituitary.
    Scallet AC; Faris PL; Beinfeld MC; Olney JW
    Brain Res; 1987 Mar; 407(2):390-3. PubMed ID: 3567652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive alterations in hyperinsulinemic but normoandrogenic MSG obese female rats.
    Gaspar RS; Benevides RO; Fontelles JL; Vale CC; França LM; Barros Pde T; Paes AM
    J Endocrinol; 2016 May; 229(2):61-72. PubMed ID: 26952035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia and glucose tolerance in obese rats with lesions of the ventromedial hypothalamus: dependence on food intake and route of administration.
    Balkan B; Steffens AB; Bruggink JE; Strubbe JH
    Metabolism; 1991 Oct; 40(10):1092-100. PubMed ID: 1943735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociative analysis of ventromedial hypothalamic obesity syndrome.
    Parkinson WL; Weingarten HP
    Am J Physiol; 1990 Oct; 259(4 Pt 2):R829-35. PubMed ID: 2221150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats.
    Dube MG; Xu B; Kalra PS; Sninsky CA; Kalra SP
    Brain Res; 1999 Jan; 816(1):38-46. PubMed ID: 9878684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse.
    Lorden JF; Caudle A
    Neurobehav Toxicol Teratol; 1986; 8(5):509-19. PubMed ID: 3785512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight.
    King BM
    Physiol Behav; 2006 Feb; 87(2):221-44. PubMed ID: 16412483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.
    Bergen HT; Mizuno TM; Taylor J; Mobbs CV
    Endocrinology; 1998 Nov; 139(11):4483-8. PubMed ID: 9794456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental and sex-specific effects of low dose neonatal monosodium glutamate administration on mediobasal hypothalamic chemistry.
    Dawson R
    Neuroendocrinology; 1986; 42(2):158-66. PubMed ID: 3513043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered behavior of adult obese rats by monosodium l-glutamate neonatal treatment is related to hypercorticosteronemia and activation of hypothalamic ERK1 and ERK2.
    Guimarães ED; de Caires Júnior LC; Musso CM; Macedo de Almeida M; Gonçalves CF; Pettersen KG; Paes ST; González Garcia RM; de Freitas Mathias PC; Torrezan R; Mourao-Júnior CA; Andreazzi AE
    Nutr Neurosci; 2017 Apr; 20(3):153-160. PubMed ID: 25683673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of morphine hyperphagia following neonatal monosodium glutamate treatment in rats.
    Bodnar RJ; Mann PE; Romero MT; Truesdell LS
    Life Sci; 1986 Mar; 38(10):947-50. PubMed ID: 3951319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of hypothalamic obesity in growing rats.
    Remke H; Wilsdorf A; Müller F
    Exp Pathol; 1988; 33(4):223-32. PubMed ID: 3068067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphagia and obesity in rats with bilateral ibotenic acid-induced lesions of the ventromedial hypothalamic nucleus.
    Shimizu N; Oomura Y; Plata-Salamán CR; Morimoto M
    Brain Res; 1987 Jul; 416(1):153-6. PubMed ID: 3476178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonirritative lesions of VMH: effects on plasma insulin, obesity, and hyperreactivity.
    King BM; Frohman LA
    Am J Physiol; 1985 Jun; 248(6 Pt 1):E669-75. PubMed ID: 3890556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hyperinsulinema and the vagus nerve in hypothalamic hyperphagia reexamined.
    Sclafani A
    Diabetologia; 1981 Mar; 20 Suppl():402-10. PubMed ID: 7014336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal hypothalamic brain grafts reduce the obesity produced by ventromedial hypothalamic lesions.
    Mickley GA; Teitelbaum H; Reier PJ
    Brain Res; 1987 Oct; 424(2):239-48. PubMed ID: 3676826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines.
    Nakagawa T; Ukai K; Ohyama T; Gomita Y; Okamura H
    Exp Anim; 2000 Oct; 49(4):239-49. PubMed ID: 11109549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contribution of type I and II corticosterone receptors in VMH lesion-induced obesity and hyperinsulinemia.
    Thomas TL; Devenport LD; Stith RD
    Am J Physiol; 1994 May; 266(5 Pt 2):R1623-9. PubMed ID: 8203642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberohypophyseal and tuberoinfundibular dopamine systems exhibit differential sensitivity to neonatal monosodium glutamate treatment.
    Dawson R; Valdes JJ; Annau Z
    Pharmacology; 1985; 31(1):17-23. PubMed ID: 2862648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.